ONS member Christine Rimkus, RN, MSN, AOCN®, clinical nurse specialist for the Siteman Cancer Center at Washington University in St. Louis, MO, and member of the St. Louis ONS Chapter, joins Chris Pirschel, ONS staff writer/producer, to discuss doxorubicin—otherwise known as the red devil—chemotherapy administration, what nurses need to know about vesicants in practice, and how to support and advocate for patients receiving doxorubicin treatment.

Music Credit: "Fireflies and Stardust" by Kevin MacLeod

Licensed under Creative Commons: By Attribution 3.0

Episode Notes

Check out these resources from today’s episode:

• The NCPD activity for this episode has expired, but you can still earn NCPD through many other Oncology Nursing Podcast episodes. Find a full list of opportunities. 
• Outpatient Oncology Drug Series: Doxorubicin Is the Infamous Red Devil
• The Case of the Vexing Vesicant
• Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers
• Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice
• Understanding and Managing Oncologic Emergencies: A Resource for Nurses (Third Edition)